Suppr超能文献

外膜囊泡保护革兰氏阴性菌免受宿主防御肽的侵害。

Outer Membrane Vesicles Protect Gram-Negative Bacteria against Host Defense Peptides.

机构信息

Section of Molecular Host Defence, Division of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.

Section of Cell Biology, Metabolism and Cancer, Division of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.

出版信息

mSphere. 2021 Aug 25;6(4):e0052321. doi: 10.1128/mSphere.00523-21. Epub 2021 Jul 7.

Abstract

Host defense peptides (HDPs) are part of the innate immune system and constitute a first line of defense against invading pathogens. They possess antimicrobial activity against a broad spectrum of pathogens. However, pathogens have been known to adapt to hostile environments. Therefore, the bacterial response to treatment with HDPs was investigated. Previous observations suggested that sublethal concentrations of HDPs increase the release of outer membrane vesicles (OMVs) in Escherichia coli. First, the effects of sublethal treatment with HDPs CATH-2, PMAP-36, and LL-37 on OMV release of several Gram-negative bacteria were analyzed. Treatment with PMAP-36 and CATH-2 induced release of OMVs, but treatment with LL-37 did not. The OMVs were further characterized with respect to morphological properties. The HDP-induced OMVs often had disc-like shapes. The beneficial effect of bacterial OMV release was studied by determining the susceptibility of E. coli toward HDPs in the presence of OMVs. The minimal bactericidal concentration was increased in the presence of OMVs. It is concluded that OMV release is a means of bacteria to dispose of HDP-affected membrane. Furthermore, OMVs act as a decoy for HDPs and thereby protect the bacterium. Antibiotic resistance is a pressing problem and estimated to be a leading cause of mortality by 2050. Antimicrobial peptides, also known as host defense peptides (HDPs), and HDP-derived antimicrobials have potent antimicrobial activity and high potential as alternatives to antibiotics due to low resistance development. Some resistance mechanisms have developed in bacteria, and complete understanding of bacterial defense against HDPs will aid their use in the clinic. This study provides insight into outer membrane vesicles (OMVs) as potential defense mechanisms against HDPs, which will allow anticipation of unforeseen resistance to HDPs in clinical use and possibly prevention of bacterial resistance by the means of OMVs.

摘要

宿主防御肽(HDPs)是先天免疫系统的一部分,构成了抵御入侵病原体的第一道防线。它们对广谱病原体具有抗菌活性。然而,众所周知,病原体能够适应恶劣的环境。因此,研究了细菌对 HDP 治疗的反应。先前的观察表明,亚致死浓度的 HDP 会增加大肠杆菌中外膜囊泡(OMVs)的释放。首先,分析了亚致死浓度的 HDP CATH-2、PMA P-36 和 LL-37 对几种革兰氏阴性菌 OMV 释放的影响。PMA P-36 和 CATH-2 的处理诱导了 OMV 的释放,但 LL-37 的处理没有。进一步研究了 OMV 的形态特性。HDP 诱导的 OMV 通常具有盘状形状。通过确定存在 OMV 时大肠杆菌对 HDP 的敏感性来研究细菌 OMV 释放的有益效果。最小杀菌浓度在存在 OMV 的情况下增加。因此,可以得出结论,OMV 释放是细菌处理受 HDP 影响的膜的一种手段。此外,OMVs 充当 HDP 的诱饵,从而保护细菌。抗生素耐药性是一个紧迫的问题,预计到 2050 年将成为死亡率的主要原因。抗菌肽,也称为宿主防御肽(HDPs),以及源自 HDP 的抗菌剂具有强大的抗菌活性和作为抗生素替代品的高潜力,因为它们不易产生耐药性。细菌已经开发出一些耐药机制,因此,全面了解细菌对 HDP 的防御将有助于它们在临床上的应用。本研究提供了对外膜囊泡(OMVs)作为潜在防御机制的深入了解,这将有助于预测 HDP 在临床应用中不可预见的耐药性,并可能通过 OMVs 预防细菌耐药性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c42/8386409/fd8d21ed3cde/msphere.00523-21-f001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验